Thank you for your interest in within3!


Clinical Trial Decision MakingFacing a go/no-go clinical trial decision, a leading pharmaceutical organization’s medical affairs’ team needed to ascertain physicians’ receptivity to utilizing the potential new compound, as well as to understand the best approach to design and execute the trial. To quickly gain this insight, they needed to conduct in-depth discussions with leading neurologists located around the country – with the different time-zones creating communication and participation barriers.

A leading pharmaceutical organization’s medical affairs team facing these challenges desired to improve their collaboration process – and results. This case study explains how they did it.

speechBubbles.jpg “I liked the ability to converse with others without having to book time or travel!”

- Clinical Thought Leader Participant

download our resource

To learn more, complete the form to request our resource.